FDA records linked by MedtechLedger identify Argon Medical Devices, Inc. as the applicant for 510(k) K263678, received October 7, 2026 and decided November 5, 2026 as substantially equivalent under the Special clearance type, with a summary statement and the Cardiovascular advisory committee. The same record lists the device as the Option™ELITE Vena Cava Filter System and Option™ELITE Vena Cava Filter 100cm System, classified under 21 CFR 870.3375 as a cardiovascular intravascular filter in Class II with product code DTK. The filing address in that record is 1445 Flat Creek Rd., Athens, TX 75751. [1][4]

Documented product and delivery components

The manufacturer’s instructions for use for the 100cm configuration list a catheter sheath introducer of 5 Fr. ID (6.5 Fr. OD) and 100cm length, an angiographic vessel dilator, a pusher with deployment marker, the Option™ELITE filter in a cartridge, and a sheath cap. The document states the kit is sterile, sterilized with ethylene oxide gas, nonpyrogenic, radiopaque, for single use only, and not to be autoclaved. A separate 70cm instructions for use carries the same kit contents with a 70cm sheath length. [2][5]

A product brochure describes a single-piece nitinol construction, an open lumen for over-the-wire delivery, a transitionless apex design, leg extensions, and curved anchors, and states that the anchor and apex design support retrieval. The brochure also lists sheath dimensions for a retrieval sheath set, including a 14F ID (4.7mm) sheath and a 16F outer sheath. These are manufacturer-published descriptions of device design, not independently verified performance data. [7]

Filing history and submission scope

An FDA letter dated September 10, 2024 addresses K242612 for the Option ELITE Vena Cava Filter System and Option™ELITE Vena Cava Filter 100cm System, under regulation number 21 CFR 870.3375, Class II, product code DTK. The letter states that the submission relied on the identical fundamental scientific technology as the predicate device, that no performance testing was necessary or performed, and that clinical testing had previously been provided under an Investigational Device Exemption and the PRESERVE study. It further states that no changes were made to the filter or delivery system and that the purpose was to incorporate PRESERVE study summary data. [4]

The 2026 record K263678 is the only linked 510(k) entry in the collection snapshot, and its decision is recorded as substantially equivalent. The snapshot’s decision counts show one SESE decision across the full collection and one SESE decision within the explicitly smaller record sample, which contains that single entry. These counts describe the linked filings at the snapshot date and are not measures of total company portfolio, sales, or safety performance. [1]

Labeling and retrieval documentation

The instructions for use carry a federal restriction statement that the device is restricted to sale by, or on the order of, a physician, and identify Option™ as a trademark of Argon Medical Devices, Inc. The labeling lists U.S. patents 7,704,266, 8,100,936, 8,162,972 and 8,715,313, and marks the device as MR Conditional. The 100cm and 70cm instructions for use are dated 06/01/2026 in revisions F and M respectively. [2][5]

Argon Medical’s product page for the Option™ELITE retrievable vena cava filter describes a low-profile 5F system intended for over-the-wire placement and snare retrieval, and the company’s IFU page links current 70cm and 100cm instructions plus Canada and Korea versions. A single-arm, prospective, multicenter non-randomized study of 100 patients is described in the 100cm instructions for use as collecting safety and efficacy data on the Rex Medical Option™ Vena Cava Filter as both a permanent and retrievable device. [3][6][9]